awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44006206-124AACF4-B245-4D8D-BEF4-0F66D9DDCD4C
Q44006206-124AACF4-B245-4D8D-BEF4-0F66D9DDCD4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44006206-124AACF4-B245-4D8D-BEF4-0F66D9DDCD4C
An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease.
P2860
Q44006206-124AACF4-B245-4D8D-BEF4-0F66D9DDCD4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44006206-124AACF4-B245-4D8D-BEF4-0F66D9DDCD4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83779ad1f4d7a597c1a1c2ce8e30ad92876c39df
P2860
Thalidomide is an inhibitor of angiogenesis